A comparison of mesenchymal precursor cells and amnion epithelial cells for enhancing cervical interbody fusion in an ovine model

Neurosurgery

Volumn 68, Issue 4, 2011, Pages 1025-1035

  Goldschlager, Tony ^a,b,d,h   Ghosh, Peter ^g   Zannettino, Andrew ^f   Williamson, Mark ^h   Rosenfeld, Jeffrey Victor ^b,e   Itescu, Silviu ^c   Jenkin, Graham ^a  

^a MONASH UNIVERSITY   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c Mesoblast Limited   (Australia)

^d MONASH MEDICAL CENTRE   (Australia)

^e ALFRED HOSPITAL   (Australia)

^f UNIVERSITY OF ADELAIDE   (Australia)

^g ROYAL NORTH SHORE HOSPITAL   (Australia)

^h GRIBBLES PATHOLOGY   (Australia)

Author keywords

Amnion epithelial cell; Anterior cervical diskectomy and fusion; Biologics; Mesenchymal stem cell; Sheep; Spine fusion; Stem cells

Indexed keywords

CALCIUM PHOSPHATE; HYDROXYAPATITE;

AMNION CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOMECHANICS; BONE DEVELOPMENT; BONE GRAFT; BONE RADIOGRAPHY; CELL THERAPY; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FLUOROSCOPY; ILIAC CREST; INTERVERTEBRAL DISKECTOMY; MESENCHYMAL STEM CELL; MORPHOMETRICS; MULTIDETECTOR COMPUTED TOMOGRAPHY; NONHUMAN; POSTOPERATIVE CARE; PRIORITY JOURNAL; SPINE FUSION; SURGICAL TECHNIQUE;

AMNION; ANIMALS; CERVICAL VERTEBRAE; EPITHELIAL CELLS; FEMALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MODELS, ANIMAL; OSTEOGENESIS; RANDOM ALLOCATION; SHEEP, DOMESTIC; SPINAL FUSION;

EID: 79952898485     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/NEU.0b013e31820d5375     Document Type: Article

References (48)

1. Ryken TC, Heary RF, Matz PG, et al. Techniques for cervical interbody grafting. J Neurosurg Spine. 2009;11(2):203-220.
2. Kalfas IH. Principles of bone healing. Neurosurg Focus. 2001;10(4):E1.
3. Pilitsis JG, Lucas DR, Rengachary SS. Bone healing and spinal fusion. Neurosurg Focus. 2002;13(6):e1.
4. Chau AM, Mobbs RJ. Bone graft substitutes in anterior cervical discectomy and fusion. Eur Spine J. 2009;18(4):449-464.
5. Silber JS, Anderson DG, Daffner SD, et al. Donor site morbidity after anterior iliac crest bone harvest for single-level anterior cervical discectomy and fusion. Spine (Phila Pa 1976). 2003;28(2):134-139. (Pubitemid 36110079)
6. Crawford CH III, Carreon LY, Djurasovic M, Glassman SD. Lumbar fusion outcomes in patients with rheumatoid arthritis. Eur Spine J. 2008;17(6):822-825.
7. Mooney V, McDermott KL, Song J. Effects of smoking and maturation on long-term maintenance of lumbar spinal fusion success. J Spinal Disord. 1999;12(5):380-385. (Pubitemid 30263378)
8. Andersen T, Christensen FB, Laursen M, Hoy K, Hansen ES, Bunger C. Smoking as a predictor of negative outcome in lumbar spinal fusion. Spine (Phila Pa 1976).2001;26(23):2623-2628. (Pubitemid 33134312)
9. Lumawig JM, Yamazaki A, Watanabe K. Dose-dependent inhibition of diclofenac sodium on posterior lumbar interbody fusion rates. Spine J. 2009;9(5):343-349.
10. Kuhns CA, Geck MJ, Wang JC, Delamarter RB. An outcomes analysis of the treatment of cervical pseudarthrosis with posterior fusion. Spine (Phila Pa 1976). 2005;30(21):2424-2429. (Pubitemid 41567606)
11. Baskin DS, Ryan P, Sonntag V, Westmark R, Widmayer MA. A prospective, randomized, controlled cervical fusion study using recombinant human bone morphogenetic protein-2 with the CORNERSTONE-SR allograft ring and theATLANTIS anterior cervical plate. Spine (Phila Pa 1976). 2003;28(12):1219-1224. (Pubitemid 36734609)
12. Leach J, Bittar RG. BMP-7 (OP-1) safety in anterior cervical fusion surgery. J Clin Neurosci. 2009;16(11):1417-1420.
13. Food and Drug Administration. FDA public health notification: life-threatening complications associated with recombinant human bone morphogenetic protein in cervical spine fusion. US Food and Drug Administration, Center for Devices and Radiological Health. Accessed July 2008. http://www.fda.gov/cdrh/safety/ 070108-rhbmp.html.
14. Liu G, Zhao L, Zhang W, Cui L, Liu W, Cao Y. Repair of goat tibial defects with bone marrow stromal cells and beta-tricalcium phosphate. J Mater Sci Mater Med. 2008;19(6):2367-2376.
15. Arthur A, Zannettino A, Gronthos S. The therapeutic applications of multipotential mesenchymal/stromal stem cells in skeletal tissue repair. J Cell Physiol. 2009;218(2):237-245.
16. NIH. Study of 3 doses of NeoFuse combined with MasterGraft Granules in subjects requiring posterolateral lumbar fusion (PLF). Accessed 2007. http:// clinicaltrials.gov/ct2/show/NCT00549913.
17. Ilancheran S, Moodley Y, Manuelpillai U. Human fetal membranes: a source of stem cells for tissue regeneration and repair? Placenta. 2009;30(1):2-10.
18. Bailo M, Soncini M, Vertua E, et al. Engraftment potential of human amnion and chorion cells derived from term placenta. Transplantation. 2004;78(10):1439-1448. (Pubitemid 39552929)
19. Ilancheran S, Michalska A, Peh G, Wallace EM, Pera M, Manuelpillai U. Stem cells derived from human fetal membranes display multilineage differentiation potential. Biol Reprod. 2007;77(3):577-588. (Pubitemid 47328622)
20. Bilic G, Zeisberger SM, Mallik AS, Zimmermann R, Zisch AH. Comparative characterization of cultured human term amnion epithelial and mesenchymal stromal cells for application in cell therapy. Cell Transplant. 2008;17(8):955-968.
21. Tyndall A, Walker U, Cope A, et al. Immunomodulatory properties of mesenchymal stem cells: a review based on an interdisciplinary meeting held at the Kennedy Institute of Rheumatology Division, London, UK, 31 October 2005. Arthritis Res Ther. 2007;9(1):301-311.
22. Kandziora F, Pflugmacher R, Scholz M, et al. Comparison between sheep and human cervical spines: an anatomic, radiographic, bone mineral density, and biomechanical study. Spine (Phila Pa 1976). 2001;26(9):1028-1037. (Pubitemid 32423652)
23. Gronthos S, Fitter S, Diamond P, Simmons PJ, Itescu S, Zannettino AC. A novel monoclonal antibody (STRO-3) identifies an isoform of tissue nonspecific alkaline phosphatase expressed by multipotent bone marrow stromal stem cells. Stem Cells Dev. Dec 2007;16(6):953-963.
24. McCarty RC, Gronthos S, Zannettino AC, Foster BK, Xian CJ. Characterisationand developmental potential of ovine bone marrow derived mesenchymal stem cells. J Cell Physiol. 2009;219(2):324-333.
25. Goldschlager T, Abdelkader A, Kerr J, Boundy I, Jenkin G. Undecalcified bone preparation for histology, histomorphometry and fluorochrome analysis. J Vis Exp. 2010 Jan 8;(35). pii: 1707. doi: 10.3791/1707.
26. Burkus JK, Dorchak JD, Sanders DL. Radiographic assessment of interbody fusion using recombinant human bone morphogenetic protein type 2. Spine (Phila Pa 1976). 2003;28(4):372-377. (Pubitemid 36232619)
27. Buchowski JM, Liu G, Bunmaprasert T, Rose PS, Riew KD. Anterior cervical fusion assessment: surgical exploration versus radiographic evaluation. Spine (Phila Pa 1976). 2008;33(11):1185-1191. (Pubitemid 351677614)
28. Kandziora F, Pflugmacher R, Scholz M, et al. Comparison of BMP-2 and combined IGF-I/TGF-ss1 application in a sheep cervical spine fusion model. Eur Spine J. 2002;11(5):482-493. (Pubitemid 35232019)
29. Kandziora F, Schmidmaier G, Schollmeier G, et al. IGF-I and TGF-beta1 application by a poly-(D,L-lactide)-coated cage promotes intervertebral bone matrix formation in the sheep cervical spine. Spine (Phila Pa 1976). 2002;27(16):1710-1723.
30. Gal JM. Mammalian spinal biomechanics, I: static and dynamic mechanical properties of intact intervertebral joints. J Exp Biol. 1993;174(1):247-280.
31. Goldschlager T, Thouas G, Edward G, Weinstein J, Jenkin G. A novel and simple method for assessing spinal biomechanics. Paper presented at: SGI 56th A.S.M- Reproductive Bioengineering-Modelling; 2008; Glasgow, Scotland.
32. Goldschlager T, Rosenfeld JV, Young IR, Jenkin G. Anterior cervical discectomy and fusion in the ovine model. J Vis Exp. 2009 Oct 5;(32). pii: 1548. doi: 10.3791/1548.
33. Zdeblick TA, Ghanayem AJ, Rapoff AJ, et al. Cervical interbody fusion cages: an animal model with and without bone morphogenetic protein. Spine (Phila Pa 1976). 1998;23(7):758-765.
34. Parfitt AM, Drezner MK, Glorieux FH, et al. Bone histomorphometry: standardization of nomenclature, symbols, and units: report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res. 1987;2(6):595-610.
35. Carlisle E, Fischgrund JS. Bone morphogenetic proteins for spinal fusion. Spine J. 2005;5(6)(Suppl):240S-249S. (Pubitemid 41700067)
36. De Coppi P, Bartsch G Jr, Siddiqui MM, et al. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol. 2007;25(1):100-106. (Pubitemid 46087908)
37. Wei JP, Zhang TS, Kawa S, et al. Human amnion-isolated cells normalize bloodglucose in streptozotocin-induced diabetic mice. Cell Transplant. 2003;12(5):545-552. (Pubitemid 36993198)
38. Kakishita K, Nakao N, Sakuragawa N, Itakura T. Implantation of human amniotic epithelial cells prevents the degeneration of nigral dopamine neurons in rats with 6-hydroxydopamine lesions. Brain Res. 2003;980(1):48-56. (Pubitemid 36836114)
39. Kakishita K, Elwan MA, Nakao N, Itakura T, Sakuragawa N. Human amniotic epithelial cells produce dopamine and survive after implantation into the striatum of a rat model of Parkinson's disease: a potential source of donor for transplantation therapy. Exp Neurol. 2000;165(1):27-34.
40. Gronthos S, Zannettino AC, Hay SJ, et al. Molecular and cellular characterisationof highly purified stromal stem cells derived from human bone marrow. J Cell Sci. 2003;116(pt 9):1827-1835. (Pubitemid 36582169)
41. Dominici M, Paolucci P, Conte P, Horwitz EM. Heterogeneity of multipotentmesenchymal stromal cells: from stromal cells to stem cells and vice versa. Transplantation. 2009;87(9)(Suppl):S36-S42.
42. Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells: the International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315-317. (Pubitemid 44269669)
43. Goldschlager T, Ghosh P, Zannettino A, et al. Cervical motion preservation using mesenchymal progenitor cells and a novel chondrogenic agent, pentosan polysulfate: a preliminary study in an ovine model. Neurosurg Focus. 2010;28(6):E4.
44. Slivka MA, Spenciner DB, SeimHB,WelchWC, Serhan HA, Turner AS. High rate of fusion in sheep cervical spines following anterior interbody surgery with absorbable and nonabsorbable implant devices. Spine (Phila Pa 1976). 2006;31(24):2772-2777. (Pubitemid 44772775)
45. Roh JS, Teng AL, Yoo JU, Davis J, Furey C, Bohlman HH. Degenerative disorders of the lumbar and cervical spine. Orthop Clin North Am. 2005;36(3):255-262. (Pubitemid 40805086)
46. Goldschlager T, Itescu S, Ghosh P, et al. Allogeneic mesenchymal precursor cells safely and effectively increase the rate and robustness of cervical interbody fusion. Paper presented at: Orthopedic Research Society 55th Annual Meeting; 2009; Las Vegas, NV.
47. Goldschlager T, Itescu S, Ghosh P, et al. Cervical interbody fusion is enhanced by allogeneic mesenchymal precursor cells in an ovine model. Spine (Phila Pa 1976). December 9, 2010. DOI: 10.1097/BRS.0b013e3181dfcec9; Accessed December 29, 2010. ,http://meta.wkhealth.com/pt/pt-core/template-journal/ lwwgateway/ media/landingpage.htm?doi=10.1097/BRS.0b013e3181dfcec9.
48. Ryan JM, Barry FP, Murphy JM, Mahon BP. Mesenchymal stem cells avoid allogeneic rejection. J Inflamm (Lond). 2005;2:8-19.